Back in July we announced the availability of the Diabetes Prevention Program (DPP), a digitally delivered National Institute of Health protocol through the Novu platform. Novu’s DPP addresses the growing type 2 diabetes epidemic in America for our clients. Today, our initial customer pilot has come to a close, and we’re pleased to share the results.
The goal of the pilot was to help participants reduce their risk of developing type 2 diabetes by losing 5-7% of their body weight—a percentage that has been clinically proven by the CDC to reduce an individual’s risk of developing the disease by almost 60%. Participants leveraged the Novu platform, which combines daily programs, rewards, community support groups and social networking with Fitbits and digital scales, as well as support from a registered dietitian. At the end of the 16-week pilot, this combination of education, access and technology resulted in:
- 90+% participation in weekly telephonic coaching sessions;
- 150+ minutes of activity per week on average per member;
- 7.8% average weight reduction;
- 81% of participants in the study met their 5% weight loss goal
Read the full press release here.
The success of the DPP supports Novu’s over-arching philosophy that member behaviors and attitudes are most likely to change when the relationship between the insurer and the insured is based on trust and collaboration. We have long believed that evolving this relationship away from traditional and transactional communication methods (think IVR and direct mail campaigns) toward a more mutually beneficial and relevant partnership is necessary—particularly in today’s health care environment where older Americans with chronic health conditions account for 66% of the nation’s health care spending, and considering that traditional campaigns usually achieve around a 1% response rate. The fact that Novu’s DPP pilot program achieved the results that it did is indicative of a more effective and cost-efficient way to reach consumers by utilizing consumer-centric communication strategies, personalization and technology, even for costly, chronic and complicated populations.
Our approach is one of engagement rather than intervention—creating and sustaining a relationship that is personal rather than patronizing. As we continue to support and catalyze health care’s engagement revolution, delivering protocols like the DPP to diverse populations—at scale—will be key to addressing our nation’s most chronic and costly problems.